Prostate Cancer, Version 3.2024.

Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
Apr 2024
Historique:
medline: 17 4 2024
pubmed: 17 4 2024
entrez: 16 4 2024
Statut: ppublish

Résumé

The NCCN Guidelines for Prostate Cancer include recommendations for staging and risk assessment after a prostate cancer diagnosis and for the care of patients with localized, regional, recurrent, and metastatic disease. These NCCN Guidelines Insights summarize the panel's discussions for the 2024 update to the guidelines with regard to initial risk stratification, initial management of very-low-risk disease, and the treatment of nonmetastatic recurrence.

Identifiants

DOI: 10.6004/jnccn.2024.0019 PMID: 38626801
pubmed: 38626801
doi: 10.6004/jnccn.2024.0019
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-150

Auteurs

Edward M Schaeffer (EM)

1Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Sandy Srinivas (S)

2Stanford Cancer Institute.

Nabil Adra (N)

3Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Yi An (Y)

4Yale Cancer Center/Smilow Cancer Hospital.

Rhonda Bitting (R)

5Duke Cancer Institute.

Brian Chapin (B)

6The University of Texas MD Anderson Cancer Center.

Heather H Cheng (HH)

7Fred Hutchinson Cancer Center.

Anthony Victor D'Amico (AV)

8Dana-Farber/Brigham and Women's Cancer Center.

Neil Desai (N)

9UT Southwestern Simmons Comprehensive Cancer Center.

Tanya Dorff (T)

10City of Hope National Cancer Center.

James A Eastham (JA)

11Memorial Sloan Kettering Cancer Center.

Thomas A Farrington (TA)

12Prostate Health Education Network (PHEN).

Xin Gao (X)

13Mass General Cancer Center.

Shilpa Gupta (S)

14Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Thomas Guzzo (T)

15Abramson Cancer Center at The University of Pennsylvania.

Joseph E Ippolito (JE)

16Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

R Jeffrey Karnes (RJ)

17Mayo Clinic Comprehensive Cancer Center.

Michael R Kuettel (MR)

18Roswell Park Comprehensive Cancer Center.

Joshua M Lang (JM)

19University of Wisconsin Carbone Cancer Center.

Tamara Lotan (T)

20The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Rana R McKay (RR)

21UC San Diego Moores Cancer Center.

Todd Morgan (T)

22University of Michigan Rogel Cancer Center.

Julio M Pow-Sang (JM)

23Moffitt Cancer Center.

Robert Reiter (R)

24UCLA Jonsson Comprehensive Cancer Center.

Mack Roach (M)

25UCSF Helen Diller Family Comprehensive Cancer Center.

Tyler Robin (T)

26University of Colorado Cancer Center.

Stan Rosenfeld (S)

27University of California San Francisco Patient Services Committee.

Ahmad Shabsigh (A)

28The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Daniel Spratt (D)

14Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Russell Szmulewitz (R)

29The UChicago Medicine Comprehensive Cancer Center.

Benjamin A Teply (BA)

30Fred & Pamela Buffett Cancer Center.

Jonathan Tward (J)

31Huntsman Cancer Institute at the University of Utah.

Richard Valicenti (R)

32UC Davis Comprehensive Cancer Center.

Jessica Karen Wong (JK)

33Fox Chase Cancer Center.

Jenna Snedeker (J)

34National Comprehensive Cancer Network.

Deborah A Freedman-Cass (DA)

34National Comprehensive Cancer Network.

Classifications MeSH